Company Quick10K Filing
Ekso Bionics
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 75 $96
10-Q 2019-10-30 Quarter: 2019-09-30
10-Q 2019-08-01 Quarter: 2019-06-30
10-Q 2019-05-01 Quarter: 2019-03-31
10-K 2019-02-28 Annual: 2018-12-31
10-Q 2018-11-07 Quarter: 2018-09-30
10-Q 2018-08-07 Quarter: 2018-06-30
10-Q 2018-05-07 Quarter: 2018-03-31
10-K 2018-03-13 Annual: 2017-12-31
10-Q 2017-11-08 Quarter: 2017-09-30
10-Q 2017-08-07 Quarter: 2017-06-30
10-Q 2017-05-09 Quarter: 2017-03-31
10-K 2017-03-15 Annual: 2016-12-31
10-Q 2016-11-09 Quarter: 2016-09-30
10-Q 2016-08-03 Quarter: 2016-06-30
10-Q 2016-05-10 Quarter: 2016-03-31
10-K 2016-03-14 Annual: 2015-12-31
10-Q 2015-11-09 Quarter: 2015-09-30
10-Q 2015-08-12 Quarter: 2015-06-30
10-Q 2015-05-11 Quarter: 2015-03-31
10-K 2015-03-19 Annual: 2014-12-31
10-Q 2014-11-12 Quarter: 2014-09-30
10-Q 2014-08-08 Quarter: 2014-06-30
10-Q 2014-05-13 Quarter: 2014-03-31
10-Q 2014-02-19 Quarter: 2013-12-31
10-Q 2013-11-14 Quarter: 2013-09-30
10-Q 2013-08-15 Quarter: 2013-06-30
10-K 2013-07-03 Annual: 2013-03-31
10-Q 2013-02-20 Quarter: 2012-12-31
10-Q 2012-12-13 Quarter: 2012-09-30
10-Q 2012-11-07 Quarter: 2012-06-30
8-K 2020-01-16 Officers
8-K 2020-01-10 Earnings, Other Events, Exhibits
8-K 2019-12-18 Enter Agreement, Other Events, Exhibits
8-K 2019-11-06 Officers
8-K 2019-10-30 Earnings, Exhibits
8-K 2019-10-22 Enter Agreement, Exhibits
8-K 2019-09-16
8-K 2019-08-01 Earnings, Exhibits
8-K 2019-06-20 Officers, Shareholder Vote
8-K 2019-05-22 Enter Agreement, Exhibits
8-K 2019-05-03 Officers, Other Events, Exhibits
8-K 2019-05-01 Earnings, Exhibits
8-K 2019-03-08 Enter Agreement, Exhibits
8-K 2019-02-28 Earnings, Exhibits
8-K 2019-01-30 Enter Agreement, Sale of Shares, Exhibits
8-K 2019-01-08 Earnings, Exhibits
8-K 2018-12-13 Officers, Exhibits
8-K 2018-11-07 Earnings, Exhibits
8-K 2018-10-30 Officers, Exhibits
8-K 2018-08-21 Enter Agreement, Other Events, Exhibits
8-K 2018-08-13 Officers, Exhibits
8-K 2018-08-07 Earnings, Exhibits
8-K 2018-07-10 Other Events, Exhibits
8-K 2018-06-07 Shareholder Vote
8-K 2018-05-09 Officers, Exhibits
8-K 2018-05-07 Earnings, Exhibits
8-K 2018-03-22 Officers, Other Events
8-K 2018-03-13 Earnings, Exhibits
8-K 2018-03-09 Officers, Exhibits
8-K 2018-01-22 Officers, Exhibits
8-K 2018-01-09 Earnings, Exhibits

Ekso Bionics Financials

EKSO Metrics, Comps, Filings

Annual | Quarterly

Business

We design, develop and sell exoskeleton technology that currently has applications in healthcare and industrial markets. Our wearable exoskeletons are worn over clothing and are mechanically controlled by a trained operator to augment human strength, endurance and mobility.

Our exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. We have sold and rented devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury, or SCI) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty or repetitive work for extended periods.

We believe the commercial opportunity for exoskeleton technology adoption is accelerating as a result of recent advancements in material technologies, electronic and electrical engineering, control technologies, and sensor and software development. Taken individually, many of these advancements have become ubiquitous in peoples' everyday lives. We believe we have learned how to integrate these existing technologies and wrap the result around a human being efficiently, elegantly and safely, supported by a robust intellectual property portfolio. We further believe we can do so across a broad spectrum of applications, from persons with lower limb paralysis to able-bodied users.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Annual)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Ultralife (ULBI) 136,507 29% 17.3 17% 141,738 35,687 89,536 25,700 23,912 8,394 145,473
Exone (XONE) 126,302 59% -67.2 -9% 73,698 18,126 41,447 24,519 -6,530 -1,793 120,487
Capstone Systems (CPST) 124,106 100% -311.9 -98% 406 1,594 226 225 -398 -398 124,076
Manitex (MNTX) 108,735 18% 29.1 -3% 226,754 134,679 239,917 43,289 -6,579 3,902 113,657
Acme United (ACU) 108,663 37% 18.3 4% 117,030 62,228 137,451 50,386 4,876 7,979 146,127
Eastman Kodak (KODK) 107,930 12% -0.2 13% 1,431,000 1,071,000 1,194,000 149,000 188,000 244,000 -44,070
Intevac (IVAC) 105,989 34% 41.8 4% 123,879 35,532 98,183 33,654 5,310 1,941 81,203
Coda Octopus Group (CODA) 99,538 67% 8.9 25% 33,344 4,428 24,874 16,584 8,224 10,203 90,912
Ekso Bionics (EKSO) 95,866 45% -4.3 -81% 25,583 20,179 12,724 5,732 -20,732 -20,001 86,544
UQM Technologies (UQM) 93,329 8% -14.4 -48% 14,974 10,813 16,247 1,301 -7,121 -6,577 94,860
Tecogen (TGEN) 85,949 47% -11.0 -22% 39,756 15,402 27,685 12,979 -8,575 -7,741 84,861
Microvision (MVIS) 83,769 38% -2.9 -202% 14,240 18,970 16,496 6,346 -28,717 -26,686 78,720
Amtech Systems (ASYS) 62,847 33% -0.8 -12% 127,426 40,850 99,921 33,398 -14,913 -11,392 8,779
Espey Mfg & Electronics (ESP) 60,030 19% 19.8 7% 35,688 7,247 36,478 7,063 2,343 2,964 58,568
Arotech (ARTX) 55,730 31% 13.2 0% 128,307 52,389 91,522 28,344 177 4,521 59,515
Highpower International (HPJ) 47,660 22% 0.0 6% 269,097 186,906 313,145 69,031 16,555 26,996 414
Fuelcell Energy (FCEL) 47,355 5% -2.7 -16% 361,434 216,667 67,595 3,263 -56,485 -46,163 122,794
Taylor Devices (TAYD) 42,439 26% 9.8 5% 41,141 4,409 32,014 8,424 2,158 3,637 35,709
Ballantyne Strong (BTN) 41,089 22% -6.4 -15% 61,112 33,840 63,259 13,918 -9,354 -6,661 42,375
Polar Power (POLA) 40,573 30% 80.7 -0% 29,561 6,384 30,342 9,240 -115 446 35,977

Balance Sheet ($'000)2013-03-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash2925,19019,55216,8465,4727,655
Accounts Receivable1,5492,0691,7802,7603,660
Inventory6221,0561,5563,0253,371
PP&E2,1022,6252,4352,2492,365
Assets2933,47432,19824,42537,98817,655
Accounts Payable7832,6941,8792,4203,156
Long-Term Debt772466,7894,8305,106
Liabilities1410,67423,39017,89416,59714,927
Stockholders' Equity22,8008,8086,53121,3912,728
Income Statement ($'000)2013-03-312014-12-312015-12-312016-12-312017-12-312018-12-31
Revenue02,9244,40914,2213811,332
Cost of Revenue3,7683,556559147,023
Gross Profit1,5591,1792,9472,0694,309
R&D3,8686,4808,8799,4835,847
SG&A114,48516,26021,85023,87125,527
Tax381216429457
Net Income-12-33,769-19,590-23,470-29,122-26,992
Cash Flow ($'000)2013-03-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash Operating-12-15,007-18,269-24,997-31,226-22,165
Cash Investing-1,487-1,492-1,096-456-131
Cash Financing3340,87914,12323,30742,5682,273